LUNA Luna Innovations Incorporated

Luna Innovations Incorporated (NASDAQ:LUNA), a company focusing on sensing, instrumentation and nanotechnology, today announced its financial results for the third quarter and nine months ended September 30, 2010.

As compared to the same quarter last year, total revenue decreased by 3%, from $8.9 million in the third quarter of 2009 to $8.6 million in the third quarter of 2010. Revenue in the company’s product and license segment improved by 49%, from $2.4 million in the third quarter of 2009 to $3.6 million in the third quarter of 2010. Technology development revenues decreased by 23% to $5.0 million for the third quarter of 2010 from $6.5 million for the third quarter of 2009.

Operating expenses improved by $1.7 million, or 31%, primarily due to the non-recurring litigation and reorganization costs in 2009 and to the company’s ongoing expense savings initiatives. The company reported a net loss attributable to common stockholders of $0.5 million, or $0.04 per common share, for the third quarter of 2010, as compared to a net loss of $2.0 million, or $0.18 per common share for the third quarter of 2009.

Adjusted EBITDA less litigation- and reorganization-related items improved to $0.9 million for the third quarter of 2010, as compared to $0.8 million for the third quarter of 2009. Adjusted EBITDA reflects the company’s earnings before interest, taxes, depreciation and amortization, non-cash stock-based compensation expense, warrant expense, and non-cash charges for impairment of intangible assets. In addition, the company achieved positive cash flow for the quarter of $0.9 million.

Dale Messick, Interim President and Chief Operating Officer, provided this overview of Luna’s results: “We are extremely pleased to report positive cash flow for the quarter along with a nearly 50% growth in our product and license revenues. As we have anticipated, with the elimination of last year’s litigation and Chapter 11 reorganization expenses from our quarterly results, we have realized significant improvement in our bottom line and in our cash flow.”

Third Quarter Financial and Business Highlights

-- Product and license revenues improved by 49%, from $2.4 million in the third quarter of 2009 to $3.6 million in the third quarter of 2010. Technology development revenues decreased by 23% to $5.0 million for the third quarter of 2010 from $6.5 million for the third quarter of 2009.

-- Gross profit for the third quarter of 2010 decreased 2% from $3.5 million in the third quarter 2009 to $3.4 million in 2010.

-- Selling, general and administrative expenses decreased by $0.5 million to $3.4 million, or 39% of total revenues for the third quarter of 2010, from $3.9 million, or 44% of total revenues, for the third quarter of 2009, driven by a reduction in legal expenses.

-- Total operating expenses decreased by 31%, from $5.4 million in the third quarter of 2009 to $3.7 million in the third quarter of 2010, primarily driven by a reduction in litigation and Chapter 11 reorganization expenses, as well as by the company’s ongoing expense savings initiatives.

-- Adjusted EBITDA excluding litigation and reorganization-related items increased to $0.9 million in the third quarter of 2010 from $0.8 million in the third quarter of 2009.

-- Net loss attributable to common stockholders improved to $0.5 million for the third quarter of 2010, compared to a net loss attributable to common stockholders of $2.0 million for the third quarter of 2009.

-- Cash and cash equivalents totaled $7.2 million at September 30, 2010, as compared to $5.7 million at September 30, 2009 and $5.2 million at December 31, 2009. At September 30, 2010, $2.5 million continued to be outstanding under the company’s $5.0 million revolving line of credit.

-- Launched the Optical Backscatter Reflectometer™(OBR) 4600 product in the third quarter offering high resolution, high sensitivity measurements of optical fiber assemblies and networks up to two kilometers in length with substantially increased speed over predecessor versions of the OBR.

--Increased the backlog for future technology development to $29.6 million at September 30, 2010 compared to $23.5 million at September 30, 2009.

Outlook for 2010

Based on information as of November 9, 2010, the company continues to expect a net loss for the year in the range of $3.0 million to $4.0 million. The company also expects revenue for the year to be in the range of $33.0 million to $34.0 million, a narrowing of the company’s previous revenue guidance of $33.0 million to $35.5 million.

Non-GAAP Measures

In evaluating the operating performance of its business, Luna’s management excludes certain charges and credits that are required by generally accepted accounting principles (“GAAP”). These non-GAAP results provide useful information to both management and investors by excluding items that the company believes may not be indicative of its operating performance, because either they are non-cash items or they are unusual items that the company does not expect to recur in the ordinary course of its business or are unrelated to the ongoing operation of the business in the ordinary course. These non-GAAP measures should be considered in addition to results and guidance prepared in accordance with GAAP, but should not be considered a substitute for, or superior to, GAAP results. The non-GAAP measures included in this press release have been reconciled to the nearest GAAP measure in the table following the financial statements attached to this press release.

Conference Call Information

As previously announced, Luna Innovations will conduct an investor conference call at 5:00 p.m. (EST) today to discuss its financial results and business developments for the third quarter of 2010. The investor conference call will be available via live webcast on the Luna Innovations website at http://www.lunainnovations.com under the tab "Investor Relations." To participate by telephone, the domestic dial-in number is 866.770.7146 and the international dial-in number is 617.213.8068. The participant access code is 55009308. Investors are advised to dial in at least five minutes prior to the call to register. The webcast will be archived on the company's website under "Webcasts and Presentations" for 30 days following the conference call.

About Luna Innovations:

Luna Innovations Incorporated (www.lunainnovations.com) is focused on sensing and instrumentation, and pharmaceutical nanomedicines. Luna develops and manufactures new-generation products for the healthcare, telecommunications, energy and defense markets. The company’s products are used to measure, monitor, protect and improve critical processes in the markets we serve. Through its disciplined commercialization business model, Luna has become a recognized leader in transitioning science to solutions. Luna is headquartered in Roanoke, Virginia.

Forward Looking Statements:

The statements in this release that are not historical facts constitute “forward-looking statements” made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. These statements include our expectations regarding financial results for the full year 2010 and capabilities of the Company’s OBR 4600 product. Management cautions the reader that these forward-looking statements are only predictions and are subject to a number of both known and unknown risks and uncertainties, and actual results, performance, and/or achievements of the Company may differ materially from the future results, performance, and/or achievements expressed or implied by these forward-looking statements as a result of a number of factors. These factors include, without limitation the fact that the outlook for full year 2010 could change, and also include, without limitations, those risks and uncertainties set forth in the Company’s periodic reports and other filings with the Securities and Exchange Commission. Such filings are available at the SEC’s website at http://www.sec.gov, and at the company’s website at http://www.lunainnovations.com. The statements made in this release are based on information available to the company as of the date of this release and Luna Innovations undertakes no obligation to update any of the forward-looking statements after the date of this release.

      Luna Innovations Consolidated Statements of Operations   Three Months Ended Nine Months Ended September 30, September 30, 2010   2009 2010 2009 (unaudited) (unaudited) Revenues: Technology development revenues $ 5,027,024 $ 6,493,741 $ 16,929,621 $ 19,795,638 Product and license revenues   3,558,118     2,381,184     8,539,953     6,234,621     Total revenues 8,585,142 8,874,925 25,469,574 26,030,259   Cost of revenues: Technology development costs 3,534,089 4,136,935 11,559,351 13,189,007 Product and license costs   1,613,499     1,231,289     4,332,600     3,275,076     Total cost of revenues   5,147,588     5,368,224     15,891,951     16,464,083       Gross Profit 3,437,554 3,506,701 9,577,623 9,566,176 Operating expense:   Selling, general and administrative 3,383,121 3,892,238

10,044,549

13,033,818 Research, development, and engineering 307,777 660,836 1,249,385 2,343,176 Litigation reserve — — — 36,303,643 Impairment of intangible assets — — — 1,310,598 Reorganization expense   53,597     872,644     161,801     872,644     Total operating expense   3,744,495     5,425,718     11,455,735     53,863,879       Operating loss (306,941 ) (1,919,017 ) (1,878,112 ) (44,297,703 )   Other income (expense): Other income (expense) 10,000 — (5,477 ) (18,167 ) Interest expense   (124,756 )   (124,208 )   (352,282 )   (422,702 )     Total other (expense)   (114,756 )   (124,208 )   (357,759 )   (440,869 )     Loss before income taxes (421,697 ) (2,043,225 ) (2,235,871 ) (44,738,572 ) Income tax expense   1,817     —     1,817     600,000       Net loss (423,514 ) (2,043,225 ) (2,237,688 ) (45,338,572 )   Preferred stock dividend   93,000     —     267,633     —    

Net loss attributable to common stockholders

$ (516,514 ) $ (2,043,225 ) $ (2,505,321 ) $ (45,338,572 )   Net loss per share: Basic and Diluted $ (0.04 ) $ (0.18 ) $ (0.19 ) $ (4.05 )   Weighted average shares: Basic and Diluted 13,188,913 11,247,749 12,890,752 11,205,575       Luna Innovations Consolidated Balance Sheets September 30, December 31, 2010   2009 (unaudited) Assets Current assets Cash and cash equivalents $ 7,152,228 $ 5,228,802 Accounts receivable, net 6,578,187 7,203,203 Inventory, net 2,984,848 2,890,364 Prepaid expenses 508,138 560,964 Other current assets   45,524     729,532     Total current assets 17,268,925 16,612,865 Property and equipment, net 3,428,076 4,129,015 Intangible assets, net 571,444 580,785 Other assets   322,002     435,259     Total assets $ 21,590,447   $ 21,757,924     Liabilities and stockholders’ equity (deficit) Liabilities not subject to compromise: Current Liabilities: Revolving line of credit $ 2,500,000 $ — Current portion of long term-debt obligation 1,164,005 — Accounts payable 1,279,763 1,142,267 Accrued liabilities 3,234,115 3,386,849 Deferred credits   1,343,348     1,027,016     Total current liabilities 9,521,231 5,556,132 Long-term debt obligation 2,993,296 —   Liabilities subject to compromise   —     19,062,000     Total liabilities 12,514,527 24,618,132   Commitments and contingencies Stockholders’ equity (deficit): Preferred stock, par value $0.001, 1,321,514 shares authorized, issued and outstanding at September 30, 2010 1,322 —

Common stock, par value $0.001, 100,000,000 shares authorized, 13,280,696 and 11,351,967 shares issuedand outstanding at September 30, 2010 and December 31, 2009, respectively

13,338 11,352 Additional paid-in capital 55,666,838 41,228,698 Accumulated deficit   (46,605,578 )   (44,100,258 )   Total stockholders’ equity (deficit)   9,075,920     (2,860,208 )   Total liabilities and stockholders’ equity (deficit) $ 21,590,447   $ 21,757,924         Luna Innovations Consolidated Statements of Cash Flows Nine months ended September 30, 2010 2009 (unaudited) Cash flows used in operating activities Net loss $ (2,237,688 ) $ (45,338,572 ) Adjustments to reconcile net loss to net cash used in operating activities Depreciation and amortization 953,630 1,504,211 Impairment of intangible assets — 1,310,598 Share-based compensation 2,616,024 2,378,968 Deferred tax expense

—

600,000 Reorganization expense in excess of cash payments

—

88,210 Reorganization accrual

—

146,964 Change in assets and liabilities: Accounts receivable 625,016 (263,620 ) Inventory (140,220 ) (1,181,901 ) Other current assets 736,834 — Other assets 71,029 (34,581 ) Accounts payable and accrued expenses (3,267,285 ) (102,956 ) Litigation reserve — 36,303,643 Deferred credits   316,332     (102,391 )     Net cash used in operating activities   (326,328 )   (4,691,427 )     Cash flows used in investing activities Acquisition of property and equipment (50,540 ) (49,295 ) Intangible property costs   (152,404 )   (152,011 )     Net cash used in investing activities   (202,944 )   (201,306 )   Cash flows provided by (used in) financing activities Payments on capital lease obligations (4,000 ) (7,927 ) Proceeds from debt obligations 2,500,000 — Payment of debt obligations (842,699 ) (5,000,000 ) Proceeds from the exercise of options and warrants   799,397     35,556     Net cash provided by (used in) financing activities   2,452,698     (4,972,371 )   Net change in cash 1,923,426 (9,865,104 ) Cash and cash equivalents—beginning of period   5,228,802     15,518,960     Cash and cash equivalents—end of period $ 7,152,228   $ 5,653,856      

Luna Innovations Incorporated Reconciliation of Net Loss to EBITDA and Adjusted EBITDA

  Three Months Ended   Nine Months Ended

September 30,

September 30, 2010   2009 2010   2009 (unaudited) (unaudited)       Net loss $ (423,514 ) $ (2,043,225 ) $ (2,237,688 ) $ (45,338,572 )   Interest 124,756 124,208 352,282 422,702 Taxes 1,817

—

1,817 600,000 Depreciation and amortization 311,652 361,365 953,630 1,504,211 Impairment of intangible assets  

—

   

—

   

—

    1,310,598   EBITDA 14,711 (1,557,652 ) (929,959 ) (41,501,061 )   Stock-based compensation 853,009 809,925 2,616,024 2,378,968 Warrant expense   27,667    

—

    149,850    

—

    Adjusted EBITDA 895,387 (747,727 ) 1,835,915 (39,122,093 )     Litigation reserve

—

—

—

36,303,643

Fees associated with litigation and reorganization

  53,597     1,556,952     284,193     4,155,008   Adjusted EBITDA less litigation and reorganization-related items $ 948,984   $ 809,225   $ 2,120,108   $ 1,336,558